A Multicenter, Open-label, Sequential, Multiple-dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Efficacy or Eritoran in Descending Age Groups of Pediatric Subjects with Severe Sepsis

Registry ID

EUCTR2010-020204-30

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE1

Sponsor

Eisai Limited

Start date

2010-11-01

Completion date

2011-02-09

Last update

2026-08-16

Conditions

• Severe Sepsis

Summary

- To evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of eritoran in pediatric subjects with severe sepsis.

Locations

• , , UK

Related clinical trials

• A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children
• Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up
• Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol
• Long-term Immunological Sequelae in Sepsis-Survivors

View on source registry